Amplification of the MYCN oncogene is strongly associated with poor prognosis in neuroblastoma (NB). In addition to MYCN amplification, many studies have focused on identifying patients with a poor prognosis based on gene expression profiling. The majority of prognostic signatures today are comprised of large gene lists limiting their clinical application. In addition, although of prognostic significance, most of these signatures fail to identify cellular processes that can explain their relation to prognosis. Here, we determined prognostically predictive genes in a data set containing 251 NBs. Gene Ontology analysis was performed on significant genes with a positive hazard ratio to search for cellular processes associated with poor prognosis. An enrichment in ribonucleoproteins (RNPs) was found. Genes involved in the stabilization and formation of the central small nucleolar RNP (snoRNP) complex were scrutinized using a backward conditional Cox regression resulting in an snoRNP signature consisting of three genes: DKC1, NHP2, and GAR1. The snoRNP signature significantly and independently predicted prognosis when compared to the established clinical risk factors. Association of snoRNP protein expression and prognosis was confirmed using tissue microarrays. Knockdown of snoRNP expression in NB cell lines resulted in reduced telomerase activity and an increase in anaphase bridge frequency. In addition, in patient material, expression of the snoRNP complex was significantly associated with telomerase activity, occurrence of segmental aberrations, and expression-based measurements of chromosomal instability. Together, these results underscore the prognostic value of snoRNP complex expression in NB and suggest a role for snoRNPs in telomere maintenance and genomic stability.
Introduction
Neuroblastoma (NB) is the second most common childhood solid tumor and is responsible for 15% of cancer-related deaths in children [1, 2] . NBs display a range of genetic alterations including amplification of the MYCN oncogene, deletions of 1p and 11q, as well as gains of 17q [3, 4] . In general, low-stage (stage 1, 2, and 4S) NBs harbor relatively few genomic alterations, and those that are detected are most often numerical changes, i.e., gains and/or losses of whole chromosomes. High-stage (stage 3 and 4) NBs, however, are associated with chromosomal instability and a relatively higher frequency of segmental aberrations [5, 6] . Although increased genetic complexity has been observed in high-stage tumors, the mechanism behind the accumulation of chromosomal aberrations in these tumors has been poorly described.
Telomeres are protective repeats of TTAGGG sequences located at the end of chromosomes [7] . One important function of the telomere is to prevent end-to-end joining of chromosomes, which otherwise could lead to the accumulation of chromosomal breaks during mitosis [8] . In normal progenitor cells, the formation and maintenance of telomeres is primarily carried out by the enzymatic complex telomerase [9] . Tumor cells, however, in addition to the conventional telomerasedependent telomere maintenance can also posses the ability to elongate the telomeric DNA through a process known as alternative lengthening of telomeres (ALT). In NB specifically, both ALT and telomerase have been described to be prognostically relevant [10, 11] and studies in other cancer types suggest that ALT and telomerase activity may not be mutually exclusive [12] [13] [14] . Telomerase is comprised of a variety of subunits, including the protein-enzymatic subunit TERT, the guiding RNA subunit TERC, as well as supportive protein complexes such as small nucleolar RNPs (snoRNPs), shelterin, and the ATPases pontin and reptin [15, 16] . It has previously been shown that the presence of all of these subunits is required for a functional telomerase complex [17] . While TERT is responsible for the enzymatic activity of the complex, TERC acts as a template and is required for guidance of the complex to the telomeres. With regard to the snoRNPs, their involvement has been associated with stabilization of TERC, allowing for proper docking of the RNA subunit with the enzymatic TERT. Both the interactions of DKC1 with TERC as well as further interaction of DKC1/TERC with TERT are facilitated by the ATPases pontin (also called RUVBL1) and reptin (also called RUVBL2). Once located at the telomeres, proteins from the shelterin complex aid in stabilizing the 3′ chromosome by altering the structural conformation of the telomere and thereby preventing it from being recognized as damaged DNA [16] .
In NB patients, increased maintenance of telomeres through elevated telomerase activity or activation of ALT as well as longer telomeres in tumor cells is associated with a poor prognosis [10, 11, 18] . Some controversy remains regarding what regulates the activity of telomerase in high-stage NBs, although there have been several reports showing that TERT can be regulated by the MYC pathway [19] [20] [21] . In this study, we report that the expression of proteins involved in the formation and stabilization of the snoRNP complex is elevated in highstage NBs and is associated with a poor prognosis. Knockdown of DKC1, the central snoRNP subunit, in NB cells led to decreased levels of TERC and a significant reduction of telomerase activity. Under these conditions, we also noted an increase in the frequency of anaphase bridges. In addition, we observed a positive correlation between snoRNP expression and telomerase activity in a panel of NB tumor samples. This suggests that elevated snoRNP expression in high-stage NB tumors may contribute to maintenance of telomere length and in doing so prevent detrimental genomic events at later stages of the disease.
Materials and Methods

Cell Culture
SK-N-BE(2)C and SK-N-SH NB cells (American Type Culture Collection, Boras, Sweden) were cultured in minimum essential medium and RPMI 1640 growth medium, respectively. Growth medium was supplemented with 10% FBS and 1% penicillin-streptomycin. Cells were cultured in a humidified incubation chamber maintained at 37°C with 5% CO 2 and 95% air (approximately 21% O 2 ).
snoRNP Signature Generation
Using a publicly available data set containing 251 NB tumors (Array Express Accession No. E-TABM-38; http://www.ebi.ac.uk/ arrayexpress/) [22] , all genes were analyzed using the Cox proportional hazards ratios. Genes were separated into those with positive hazard ratios (HR; poor prognosis) and negative HRs (good prognosis). Genes were then further ranked according to significance of prognostic value based on a Bonferroni-corrected P value. Using a significance cutoff of P < .0001, a Gene Ontology (GO) analysis was performed, using the functional annotation tool in DAVID [23] , on genes with a positive HR (n = 643). After finding a significant enrichment of RNP-associated genes, a literature review was performed to examine genes essential for the formation and/or stabilization of the central RNP complex. These identified genes were then discriminated using a backward conditional Cox regression model resulting in three significant genes. Calculating the mean rank values of these three genes then generated the snoRNP signature score.
Gene Expression Arrays
Using the 251-tumor data set (Array Express Accession No. E-TABM-38; http://www.ebi.ac.uk/arrayexpress/) [22] , the three-gene snoRNP signature score was used to divide patients into high versus low expressing groups determined by the median expression of the signature score. Overall survival (OS) and event-free survival (EFS) were examined by Kaplan-Meier analysis.
Validation of the snoRNP signature was performed in an independent data set consisting of 88 tumors (NCBI GEO Accession No. GSE 16476; http://www.ncbi.nlm.nih.gov/geo/) [5] . Kaplan-Meier analysis was performed as described above. Mantel-Cox log-rank analysis was performed and P values < .05 were considered significant.
To determine the independent predictive capacity of examined variables in both data sets, multivariate Cox regression analysis was performed. International Neuroblastoma Staging System (INSS) stage was examined as categorical. P values of HRs < 0.05 were considered significant.
Single Nucleotide Polymorphism (SNP) Array
Two hundred nanograms of DNA from 84 of the 88 tumors used for gene expression analysis (GSE 16476) [5] was hybridized to Illumina Human CNV370/660/Omnia BeadChips (Illumina Inc, San Diego, CA) and processed according to the manufacturer's recommendations. Normalized allelic intensity values were subjected to an additional normalization step using the tQN software (http://baseplugins. thep.lu.se/wiki/se.lu.onk.IlluminaSNPNormalization) for estimation of B-allele frequency and log 2 ratio. Constitutional copy number polymorphisms were excluded on the basis of comparison with the Database of Genomic Variants (http://projects.tcaq.ca/variation, GRCh37 genome build). Identified segments of copy number imbalances by the B-allele frequency segmentation software (http://baseplugins.thep. lu.se/wiki/se.lu.onk.BAFsegmentation) were in addition manually analyzed and verified with the use of BeadStudio 3.1 software with Illumina Genome Viewer.
siRNA Transfection for Quantitative Real-Time Polymerase Chain Reaction Analysis
Cells were seeded in six-well plates at a density of 150,000 cells per well in medium (as described above). Cells were left to attach overnight. The medium was then removed and replaced with 2 ml of Opti-MEM (Invitrogen, Stockholm, Sweden). Transfection was carried out using Lipofectamine 2000 transfection agent and two predesigned silencer select siRNAs (Invitrogen) targeting each gene as well as a negative control scrambled siRNA (siRNA Negative Control #2). An siRNA concentration of 10 nM was used for all transfections. Cells were left in the transfection medium for 6 hours after which the transfection medium was removed and replaced with 2 ml of normal cell culture medium. Cells were then left in standard culture conditions for 48 or 72 hours before harvest.
Quantitative Real-Time Polymerase Chain Reaction
Cells were harvested and lysed in TRIzol (Invitrogen). Five freshfrozen tumor tissue samples (Ethical Permit LU 389-98 and parent consent) were first treated with RNAlater-ice (Invitrogen) according to the manufacturer's protocol. Tissue samples were then homogenized with a scalpel on dry ice and lysed in TRIzol. The aqueous phase was obtained using chloroform at a concentration of 200 μl per 1 ml of TRIzol. RNA from this phase was extracted using RNeasy spin columns (Qiagen, Hilden, Germany) according to the manufacturer's protocol. Extracted RNA was DNAse treated and washed using Microcon spin columns (Millipore, Solna, Sweden). cDNA synthesis was performed using random primers and Multitranscribe Reverse Transciptase (Applied Biosystems, Stockholm, Sweden). Resulting cDNA was analyzed using SYBR Green PCR Master Mix (Applied Biosystems) on a 7300 Sequence Detection System (Applied Biosystems). The comparative C t method was used to compare relative expression levels [24] . Three housekeeping genes (UBC, YWHAZ, and SDHA) were used for normalization. Primer sequences and assay efficiencies are displayed in Table W2 .
Anaphase Bridge Analysis
Cells were seeded in six-well plates at a density of 75,000 cells per well on sterilized glass coverslips and siRNA transfections were carried out as above. Seventy-two hours post transfection, cells were fixed on the coverslips in 3:1 methanol/glacial acetic acid for 20 minutes. Fixed cells were then stained using hematoxylin and eosin. Scoring of the stained cells was performed manually, counting the number of normal and abnormal (anaphase bridge) anaphase cells. The counts in each group were compared using Student's t test, where P < .05 was considered significant.
Telomeric Repeat Amplification Protocol
For the five tumor tissue samples examined [same tumors used for quantitative real-time polymerase chain reaction (QPCR) analysis], approximately 30 mg of tissue was collected from each sample on dry ice. For cell line experiments, cells were seeded in six-well plates at a density of 200,000 cells per well. siRNA transfections were carried out as described above. Cells were cultured for 48 hours after transfection before harvesting. Harvesting and telomeric repeat amplification protocol (TRAP) assays were carried out according to the manufacturer's protocol (Millipore; TRAPeze XL Telomerase Detection Kit). In brief, homogenized tissue or cells were harvested and lysed in CHAPS lysis buffer supplemented with RNase inhibitor at a concentration of 200 units/ml (Life Technologies, Stockholm, Sweden). Debris was pelleted by centrifugation and protein/supernatant was transferred to a new tube. Protein concentration of the supernatant was determined using a spectrophotometer (Thermo Scientific Nanodrop ND-1000). PCR was then performed in a thermocycler (Eppendorf Mastercycler Gradient) using TRAPeze XL reaction mix, Taq polymerase (Life Technologies), and sample extract. Following PCR, relative telomerase activity was determined using a fluorescence plate reader (BioTek Synergy 2).
Tissue Microarray
Paraffin-embedded cores from 42 NB tumors were obtained from the Versteeg laboratory in Amsterdam. Immunohistochemical staining was performed using an anti-DKC1 antibody (Sigma-Aldrich, Stockholm, Sweden; HPA000447) diluted 1:100 and with an anti-NHP2 antibody (Biosite, Stockholm, Sweden; 15128-1-AP) diluted 1:200. Stainings were performed without knowledge of the biologic or clinical characteristics of any specific cores. Signed consent was obtained from each patient's parents for documentation, biologic studies, and analysis. The regional ethics review boards of the participating institutes have approved the study. Cores were scored on a scale from 0 to 3 based on intensity of staining in tumor cells. Scoring was performed independently by two persons. Kaplan-Meier analysis was performed based on tissue microarray (TMA) scores, and Mantel-Cox log-rank P value < .05 was considered significant. Additional TMAs from DP-UV in Valencia with 68 cases of NB were used (Ethical Approval No. 59CI8ABR2002). The TMA sections were analyzed by DKC1 immunohistochemistry as described above.
Statistical Analyses
The significance of prognostic information given by gene expression in array data was assessed using the Cox proportional HRs and corresponding Bonferroni-corrected P values. Independent contribution of genes and the reduction of number of genes in the snoRNP signature score were determined using backward conditional Cox regression analysis. EFS and OS analyses were performed using Kaplan-Meier survival plots and corresponding Mantel-Cox log-rank tests. Independence of the snoRNP signature score from clinical parameters and other NB defining characteristics was determined using entered Cox regression analysis. Correlation analyses were determined using Pearson product-moment correlation coefficients. Group comparisons in cell line experiments were carried out using Student's t test.
Results
Enrichment of snoRNPs among Prognostically Significant Genes in NB
To search for processes associated with prognosis in NB, a gene expression data set consisting of 251 tumors was examined [22] . We employed Cox proportional HR test on all genes to find the most significant predictive genes in the data set. Background-corrected GO analysis was then performed on all genes with a positive HR and a significance cutoff of P < .001 (Table W1) to search for functional Translational Oncology Vol. 6, No. 4, 2013 snoRNPs and Prognosis of Neuroblastoma von Stedingk et al.
clusters of genes associated with poor prognosis. Upon GO analysis, a significant enrichment of RNP and RNP complex-associated genes was found (Table 1A) . Interestingly, top ranking among these enriched genes was DKC1, the core enzymatic subunit of the snoRNP complex [25] . Further examination of the gene list revealed that four additional genes (GAR1, NHP2, RUVBL1, and RUVBL2) crucial to the formation and/or stabilization of the snoRNP complex [25] [26] [27] [28] were included among the top predictors of poor prognosis. When performing a backward conditional Cox regression analysis of the five genes, three of the genes (DKC1, GAR1, and NHP2) were found to be independent predictors of patient survival (Table 1B) . Interestingly, these genes comprise three of the four core components of the snoRNP complex, the fourth of which, NOP10, was not present in the data set.
snoRNP Signature Score Is an Independent Predictor of Prognosis
Next, we calculated an snoRNP signature score, based on the mean rank values of DKC1, GAR1, and NHP2. Application of the snoRNP signature score significantly predicted patient OS and EFS (Figure 1,  A and B ; log-rank P = 1.3 × 10 −10 and 8.5 × 10 −12 , respectively). Taking into consideration the heavy influence MYCN amplification has on progression and prognosis of the disease [4] , we examined the predictive capacity of the snoRNP gene signature in all patients not harboring an MYCN amplification. Once again, the snoRNP signature was significantly associated with OS and EFS prognoses (Figure 1 , C and D; log-rank P = 3.0 × 10 −6 and 1.9 × 10 −7 , respectively). In addition, when compared to both MYCN amplification as well as an NB-derived MYC pathway activity score [29] in a multivariate analysis, the snoRNP signature was independently associated with prognosis [ Figure W1C ; HR = 17.3, 95% confidence interval (CI) = 2.2-135.7]. In the clinic, it is important to identify the subgroup of high-risk patients that does not respond to intense treatment and displays a dismal prognosis. We therefore examined the prognostic value of the snoRNP signature score in the subset of high-stage (stage 4) patients. Once again, the snoRNP signature significantly identified a subgroup of patients with a worse prognosis ( Figures W1A and 1E ; log-rank P = 3.0 × 10 −5 ). In addition, upon performing a multivariate Cox regression analysis across all patients, snoRNP signature score was an independent prognostic marker when compared to the clinically used parameters age at diagnosis, INSS stage, and MYCN amplification ( Figure 1F ; HR = 846.9, 95% CI = 31.7-22620.4).
To validate the predictive capacity of the snoRNP signature, a second independent data set consisting of 88 tumors was examined [5] . As was found in the 251-tumor data set, snoRNP signature score was a significant predictor of both OS and EFS (Figure 2 , A and B, log-rank P = 3.6 × 10 −9 and 2.8 × 10 −7 , respectively). This association to prognosis was independent of MYCN amplification status (Figure 2 , C and D, log-rank P = 1.0 × 10 −4 and 0.003, respectively). Furthermore, the snoRNP signature displayed independent prognostic value when compared to MYCN amplification and MYC pathway activity ( Figure W1D ; HR = 8.2, 95% CI = 1.5-45.7). In addition, in this validation cohort, the snoRNP signature score could significantly identify a subgroup of ultrahigh-risk patients within patients already classified as stage 4 ( Figures W1B and 2E , log-rank P = .009). As in the 251-tumor data set, the snoRNP score fell out as an independent prognostic marker when compared to the commonly used clinical parameters ( Figure 2F ; HR = 59580, 95% CI = 12.4-2.9 × 10 8 ).
snoRNP Protein Expression Predicts Patient Survival and Correlates with snoRNP Expression Signature
To determine if the expression of snoRNPs also correlated to prognosis at the protein level, a TMA consisting of 42 tumors (42 of the 88 tumors included in [5] ) was stained for both the core subunit DKC1 and cofactor NHP2. Tumor cell staining intensity was scored on a scale from 0 to 3 ( Figure 3A) . Indeed, both DKC1 and NHP2 protein expression significantly predicted patient survival (Figure 3 , B and C; log-rank P = .011, log-rank P = .022, respectively). In an independent TMA consisting of 68 tumors, DKC1 staining intensity again displayed a significant association with patient survival ( Figure 3D ; log-rank P = .020). In addition, comparing matched gene expression data with protein staining in the 42 examined tumors, protein staining displayed significant positive correlations with snoRNP signature score for both DKC1 and NHP2 (Figure 3, E and F, respectively) . The observation of a strong correlation between mRNA and protein expression is of importance. It indicates that the extrapolation from mRNA to protein expression can be made and it allows for utilization of both mRNA and protein-based assessment of snoRNP expression levels in NBs.
DKC1 Regulates Telomerase Activity in NB Cell Lines
After establishing that snoRNP expression is significantly associated with outcome, we sought to clarify what function this complex may have in aggressive NBs. It has previously been shown in multiple cellular systems that snoRNPs, specifically DKC1, are required for the formation of a functional telomerase complex [15] . Taking this into consideration, along with previous implications of telomere regulation in aggressive NBs [10, 11, 18] , we examined whether the snoRNP core subunit DKC1 modulated telomerase activity in NB. Upon siRNAmediated knockdown of DKC1 in the NB cell lines SK-N-BE(2)c and SK-N-SH (MYCN-amplified and non-amplified, respectively), we detected a significant reduction in expression levels of the telomerase RNA subunit TERC in both cell lines (Figure 4 , A-C). In addition, assessment of telomerase enzymatic activity using the TRAP assay revealed reduced telomerase activity in both the MYCN-amplified and non-amplified cell systems upon knockdown of DKC1 ( Figure 4D ). Expression analysis of the telomerase enzymatic subunit TERT did, however, not reveal modulation upon DKC1 depletion ( Figure 4E) , supporting the notion that altered DKC1 levels regulate telomerase activity in a manner independent of TERT modulation. Despite previous reports suggesting TERT induction through the MYC pathway [19] [20] [21] , TERT expression was substantially higher in the MYCNnon-amplified SK-N-SH cells when compared to the MYCN-amplified SK-N-BE(2)C cells. Taking into consideration the similar levels of telomerase activity detected between the two cell lines ( Figure 4D ), this surprising difference in TERT expression further supports the idea that telomerase activity levels in NB do not mirror TERT expression levels. Interestingly, the observed effects on TERC and telomerase activity were detected despite a modest knockdown of DKC1 at the protein level, suggesting a potential rate-limiting role of DKC1 in telomerase regulation. In addition, the previously reported importance of telomerase activity in NB and the independence of snoRNP score from TERT expression ( Figure W1 , C and D) support the notion that snoRNPs independently modulate telomerase activity levels in NB. To evaluate the association between snoRNP expression and telomerase activity in vivo, a panel of five NB tumors was examined. QPCR-based analysis of snoRNP (DKC1, GAR1, and NHP2) expression displayed a significant positive correlation to telomerase activity ( Figure 4F ; r = 0.914, P = .029) as determined by TRAP assay.
Loss of DKC1 Results in Increased Frequency of Anaphase Bridges
Considering the importance of telomere maintenance during repeated cell divisions [30] , we examined whether the observed reduction in telomerase activity following DKC1 depletion may have an effect on the ability of NB cells to undergo mitosis. It has previously been shown that defects in telomere maintenance can result in the formation of anaphase bridges during the separation of dividing cells [31] . In both cell lines, even modest DKC1 reduction resulted in a significant increase in the frequency of anaphase bridge formation ( Figure 5, A and B) . This supports the idea that DKC1 knockdown resulted in failure of chromosome protection because of a lack of telomere maintenance.
snoRNP Expression Correlates with Segmental Aberrations and Chromosomal Instability
Taking into consideration the consequences of altered DKC1 expression on telomerase activity and chromosome separation during cell division, we hypothesized that divergent expression of snoRNPs might be associated with an overall increase in genetic aberrations. We therefore examined the relationship between snoRNP expression and various measurements of genomic stability. SNP array data matched to 84 of the 88 tumors used for gene expression analysis ( Figure 2 ) [5] were analyzed for genetic events in correlation to snoRNP signature score. The snoRNP signature score displayed a significant positive correlation with the presence of segmental aberrations, while displaying a negative correlation to numerical changes ( Figure 5C ). Furthermore, within the 88 tumors, we found a significant positive correlation between the snoRNP signature score and genomic complexity (GC) as measured by implementation of a previously published GC signature ( Figure 5D , top panel ) [32] . The observed positive correlation between snoRNP score and GC signature was further validated in the 251-tumor data set ( Figure 5E , top panel ). Interestingly, even within stage 4 tumors, snoRNP score and GC signature were positively correlated ( Figure 5 , D and E, bottom panels).
Discussion
Predicting NB patient prognosis based on multigene signatures has been widely explored and, in some instances, with great success [ [33] [34] [35] [36] [37] [38] [39] . With the common methods used to compile these gene signatures, comparing expression patterns based on differential survival in the patients, the gene lists often consist of a large number of genes without clear commonality with regard to functions and/or molecular pathways. Using NB gene expression arrays, we searched for com-monalities among the top prognostic genes with use of GO analysis. We further describe a three-gene signature consisting of genes central in the formation and stabilization of the snoRNP protein complex. The snoRNP signature displayed highly significant prognostic value and was an independent predictor of poor prognosis when compared with the common clinically used parameters, such as age at diagnosis, INSS stage, and MYCN amplification, as well as MYC pathway activity and TERT expression. The fact that the signature consists of only three genes can allow for simple PCR-based patient testing, as Garcia et al. have recently shown [40] . In further support of its clinical relevance, application of the signature to pre-defined stage 4 patients identified an ultrahigh-risk group of patients (OS < 20%), who display a dismal prognosis despite intense treatment regimens. To identify this patient group at diagnosis could justify inclusion of these patients in clinical trials with new treatment strategies and/or therapies.
Previous studies have displayed an association between telomere maintenance and prognosis in NB [10, 11, 18] . The mechanism by which telomerase activity is regulated in high-stage tumors has, however, remained elusive. In addition, how telomerase activity contributes to tumor progression has been a topic of debate. Recent studies have, however, shed some light on this question [41, 42] . By employing a mouse model system for prostate cancer and T cell lymphomas, it was shown that a lack of telomerase activity during early stages of tumor development promoted tumor formation. Loss of telomeres resulted in formation of breakage-fusion bridge cycles during mitosis leading to the accumulation of amplifications and deletions at the affected sites. Although accumulation of such genetic events may be beneficial during early progression, the acquisition of many genetic events can lead to cellular crisis and initiation of cell death. As a result, high-risk tumors require a mechanism to stabilize the genome to prevent cellular crisis from occurring. In the aforementioned studies, it was shown that reactivation of telomerase activity through conditional expression of TERT stabilized the genome in these genetically complex tumors, preventing activation of apoptotic pathways and allowing for dissemination of the disease [41, 42] .
We, however, do not find TERT expression to be consistently associated with prognosis in NB ( Figure W1, A and B) . However, we do show a significant association between the expression of the telomerase-associated snoRNP complex and survival. Furthermore, upon knockdown of the central snoRNP subunit DKC1, we observed a significant reduction in expression of the telomerase RNA subunit TERC accompanied by lower telomerase activity. This suggests a potential role of DKC1 and other snoRNPs in the elevated telomerase activity observed in advanced tumors. In line with this hypothesis, decreased DKC1 expression resulted in an increased frequency of anaphase bridge formation, a genetic event associated with loss of telomeres resulting in increased chromosomal instability [31] . Interestingly, loss of DKC1 and other snoRNPs such as NHP2 are associated with dyskeratosis congenita, a disease characterized by a loss of telomerase activity and early aging of the patients. In addition to early aging, dyskeratosis congenita patients display an increased risk for developing multiple cancer forms, which has been attributed to a telomerase deficiency-dependent increase in genetic instability [43] . However, it has been reported in multiple cancer types (breast, colon, and prostate), and now in line with our data in NB, that high DKC1 expression is associated with advanced disease and poor prognosis [44] [45] [46] . Taken together, public data and our data suggest that similar to the previously described model regarding TERT loss and reactivation, a low expression of snoRNPs may allow for the development of genetic alterations during pre-clinical tumor development. In advanced tumors, a subsequent up-regulation of snoRNPs may aid in telomere maintenance and stabilization of the genome, which in turn prevents highly complex tumors from going into cellular crisis. This provides an explanation for the poor prognosis and the high level GC signature observed among patients with high snoRNP expression. Figure W1 . snoRNP signature score prognostic value is independent of MYC pathway activity and TERT expression. (A and B) Kaplan-Meier analyses and corresponding log-rank P values for EFS in stage 4 patients according to snoRNP signature score. Group divisions decided by median snoRNP score (HIGH, above median; LOW, below median). Analyses were performed in the Oberthuer 251-tumor data set (A) and the Versteeg 88-tumor data set (B). (C and D) Multivariate Cox regression analysis including snoRNP score, MYCN amplification status, MYC pathway activity, and TERT mRNA expression. Accompanying HRs (Exp(B)) with 95% CIs and significance values are provided. Analyses were performed in the Oberthuer 251-tumor data set (C) and the Versteeg 88-tumor data set (D).
